Remote Ischemic Perconditioning as an Adjunct Therapy to Thrombolysis in Patients With Acute Ischemic Stroke

Background and Purpose— Remote ischemic preconditioning is neuroprotective in models of acute cerebral ischemia. We tested the effect of prehospital rPerC as an adjunct to treatment with intravenous alteplase in patients with acute ischemic stroke. Methods— Open-label blinded outcome proof-of-concept study of prehospital, paramedic-administered rPerC at a 1:1 ratio in consecutive patients with suspected acute stroke. After neurological examination and MRI, patients with verified stroke receiving alteplase treatment were included and received MRI at 24 hours and 1 month and clinical re-examination after 3 months. The primary end point was penumbral salvage, defined as the volume of the perfusion–diffusion mismatch not progressing to infarction after 1 month. Results— Four hundred forty-three patients were randomized after provisional consent, 247 received rPerC and 196 received standard treatment. Patients with a nonstroke diagnosis (n=105) were excluded from further examinations. The remaining patients had transient ischemic attack (n=58), acute ischemic stroke (n=240), or hemorrhagic stroke (n=37). Transient ischemic attack was more frequent (P=0.006), and National Institutes of Health Stroke Scale score on admission was lower (P=0.016) in the intervention group compared with controls. Penumbral salvage, final infarct size at 1 month, infarct growth between baseline and 1 month, and clinical outcome after 3 months did not differ among groups. After adjustment for baseline perfusion and diffusion lesion severity, voxelwise analysis showed that rPerC reduced tissue risk of infarction (P=0.0003). Conclusions— Although the overall results were neutral, a tissue survival analysis suggests that prehospital rPerC may have immediate neuroprotective effects. Future clinical trials should take such immediate effects, and their duration, into account. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT00975962.

[1]  H. Bøtker,et al.  Remote Ischemic Perconditioning in Thrombolysed Stroke Patients: Randomized Study of Activating Endogenous Neuroprotection – Design and MRI Measurements , 2013, International journal of stroke : official journal of the International Stroke Society.

[2]  W. Whiteley,et al.  The differential diagnosis of suspected stroke: a systematic review. , 2013, The journal of the Royal College of Physicians of Edinburgh.

[3]  E. Lo,et al.  Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis , 2012, Neurology.

[4]  D. Hess,et al.  Remote Ischemic Perconditioning Is Effective Alone and in Combination With Intravenous Tissue-Type Plasminogen Activator in Murine Model of Embolic Stroke , 2012, Stroke.

[5]  J. Saver,et al.  Statistical Analysis of the Primary Outcome in Acute Stroke Trials , 2012, Stroke.

[6]  C. Iadecola,et al.  Stroke research at a crossroad: asking the brain for directions , 2011, Nature Neuroscience.

[7]  C. Hahn,et al.  Remote Ischemic Per-Conditioning: A Novel Therapy for Acute Stroke? , 2011, Stroke.

[8]  A. Redington,et al.  Repeated Remote Ischemic Postconditioning Protects Against Adverse Left Ventricular Remodeling and Improves Survival in a Rat Model of Myocardial Infarction , 2011, Circulation research.

[9]  M. Perez-Pinzon,et al.  Remote Ischemic Limb Preconditioning After Subarachnoid Hemorrhage: A Phase Ib Study of Safety and Feasibility , 2011, Stroke.

[10]  P. Barber,et al.  Ischemic diffusion lesion reversal is uncommon and rarely alters perfusion-diffusion mismatch , 2010, Neurology.

[11]  R. Carpenter,et al.  Remote Ischemic Preconditioning for Cerebral and Cardiac Protection During Carotid Endarterectomy: Results From a Pilot Randomized Clinical Trial , 2010, Vascular and endovascular surgery.

[12]  C. Terkelsen,et al.  Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial , 2010, The Lancet.

[13]  I. Konstantinov,et al.  Remote Ischemic Conditioning: Evolution of the Concept, Mechanisms, and Clinical Application , 2010, Journal of cardiac surgery.

[14]  Charalampos Kossyvakis,et al.  Cardioprotective role of remote ischemic periconditioning in primary percutaneous coronary intervention: enhancement by opioid action. , 2010, JACC. Cardiovascular interventions.

[15]  Kim Mouridsen,et al.  Predicting Tissue Outcome From Acute Stroke Magnetic Resonance Imaging: Improving Model Performance by Optimal Sampling of Training Data , 2009, Stroke.

[16]  U. Dirnagl,et al.  Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use , 2009, The Lancet Neurology.

[17]  M. Ginsberg.  Current status of neuroprotection for cerebral ischemia: synoptic overview. , 2009, Stroke.

[18]  R. Bammer,et al.  Optimal Tmax Threshold for Predicting Penumbral Tissue in Acute Stroke , 2009, Stroke.

[19]  M. Kaste,et al.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. , 2008, The New England journal of medicine.

[20]  Keith Muir,et al.  Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial , 2008, The Lancet Neurology.

[21]  G. Steinberg,et al.  Limb remote-preconditioning protects against focal ischemia in rats and contradicts the dogma of therapeutic time windows for preconditioning , 2008, Neuroscience.

[22]  I. Konstantinov,et al.  Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: first demonstration of remote ischemic perconditioning. , 2007, American journal of physiology. Heart and circulatory physiology.

[23]  B. Rosen,et al.  Infarct Prediction and Treatment Assessment with MRI-based Algorithms in Experimental Stroke Models , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[24]  L. Østergaard,et al.  Characterizing physiological heterogeneity of infarction risk in acute human ischaemic stroke using MRI. , 2006, Brain : a journal of neurology.

[25]  Søren Christensen,et al.  Automatic selection of arterial input function using cluster analysis , 2006, Magnetic resonance in medicine.

[26]  A. Šimundić,et al.  [Diagnostic accuracy]. , 2006, Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti.

[27]  Jane C Khoury,et al.  Revascularization End Points in Stroke Interventional Trials: Recanalization Versus Reperfusion in IMS-I , 2005, Stroke.

[28]  B. Rosen,et al.  Tracer arrival timing‐insensitive technique for estimating flow in MR perfusion‐weighted imaging using singular value decomposition with a block‐circulant deconvolution matrix , 2003, Magnetic resonance in medicine.

[29]  Christina Gloeckner,et al.  Modern Applied Statistics With S , 2003 .

[30]  Gary A. Ford,et al.  Diagnostic Accuracy of Stroke Referrals From Primary Care, Emergency Room Physicians, and Ambulance Staff Using the Face Arm Speech Test , 2003, Stroke.

[31]  F. Buonanno,et al.  Predicting Tissue Outcome in Acute Human Cerebral Ischemia Using Combined Diffusion- and Perfusion-Weighted MR Imaging , 2001, Stroke.

[32]  D. Bates,et al.  Mixed-Effects Models in S and S-PLUS , 2001 .

[33]  Gary Duckwiler,et al.  Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging , 2000, Annals of neurology.

[34]  M. Moskowitz,et al.  Pathobiology of ischaemic stroke: an integrated view , 1999, Trends in Neurosciences.

[35]  T Brott,et al.  The ABCs of measuring intracerebral hemorrhage volumes. , 1996, Stroke.

[36]  R. Kloner,et al.  Regional Ischemic 'Preconditioning' Protects Remote Virgin Myocardium From Subsequent Sustained Coronary Occlusion , 1993, Circulation.

[37]  W. Ganz,et al.  The thrombolysis in myocardial infarction (TIMI) trial. , 1985, The New England journal of medicine.

[38]  H. S. Mueller,et al.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.